Find here Marinomed’s corporate news and Ad-hoc news.
Marinomed to pause issuing of tranches of Convertible Notes Funding Program to Nice & Green
Press release
Marinomed Biotech AG: Annual General Meeting elects Dr. Elisabeth Lackner and Ulrich Kinzel to the Supervisory Board
Press release
Marinomed Biotech AG reports strong 1st quarter 2022: continued growth trajectory for Carragelose
Press release
Marinomed Biotech AG enters into license agreement with Procter & Gamble on Carragelose® products
Adhoc-Announcement
Lucia Mayr-Harting, MSc
Public Relations